The biologics CDMO market revenue was projected at $13,173.7 million in the year 2021. This is likely to rise to $31,839.7 million by 2030, at a compound annual growth rate of 10.3% from 2021 to 2030. This can be credited to the increasing need for medicines, growing aging population, heavy funding for healthcare infrastructure, and the introduction of new products. … Continua a leggere→